Skip to Main Content

HelixTalk Episode #35 - Empagliflozin and dulaglutide

Date posted: November 24, 2015, 6:00 am

In this episode, we discuss two new anti-diabetic medications: empagliflozin (Jardiance) and the EMPA-REG OUTCOME trial as well as dulaglutide (Trulicity), a new GLP1 agonist.